XML 85 R73.htm IDEA: XBRL DOCUMENT v3.22.2.2
Investments in and Advances to Joint Ventures - Summary of Financial Information for Consolidated Joint Ventures (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Schedule Of Equity Method Investments [Line Items]          
Current assets $ 1,610,798   $ 1,610,798   $ 1,632,351
Total assets 4,094,990   4,094,990   3,830,940
Current liabilities 1,149,479   1,149,479   1,030,784
Total liabilities 2,089,898   2,089,898   1,893,828
Total joint venture equity 1,953,066   1,953,066   1,900,768
Revenue 1,134,370 $ 956,050 3,092,160 $ 2,710,103  
Costs 872,423 734,652 2,388,095 2,084,062  
Net income attributable to Parsons Corporation 29,571 19,358 68,533 35,099  
Net income attributable to noncontrolling interests 14,024 7,411 21,685 17,711  
Consolidated Joint Ventures          
Schedule Of Equity Method Investments [Line Items]          
Current assets 268,561   268,561   246,342
Noncurrent assets 7,885   7,885   2,180
Total assets 276,446   276,446   248,522
Current liabilities 169,233   169,233   175,637
Total liabilities 169,233   169,233   175,637
Total joint venture equity 107,213   107,213   $ 72,885
Revenue 130,344 101,816 333,967 296,685  
Costs 101,882 86,726 289,485 260,129  
Net income attributable to Parsons Corporation 28,462 15,090 44,482 36,556  
Net income attributable to noncontrolling interests $ 14,024 $ 7,411 $ 21,685 $ 17,711